Policy & Advocacy: Regulatory Strategy for Pharma & Life Sciences
SILREAL facilitates dialogue on healthcare frameworks and cross-border collaboration. By combining in-depth policy analysis with trusted networks, we create compliant and sustainable strategies for life science companies seeking faster access to the Chinese market and stronger positioning in Europe.
Our Expertise
We support pharma and life science policy consulting and market entry strategy with expertise that spans EU-China regulatory frameworks, stakeholder mapping, and international government affairs.
Regulatory & Policy Strategy
-
EU HTA & reimbursement alignment
-
China NMPA submissions, localization, GMP compliance
Government Affairs & Public Policy
-
Stakeholder mapping & ministry engagement
-
Cross-border advocacy positioning
Policy Monitoring & Intelligence
-
Real-time tracking of German and Chinese reforms
-
Actionable alerts on pricing, digital-health, and data rules
International Policy Exchange
- EU-Asia forums on disease management and reimbursement policies
- Best-practice transfer for long-term alignment
Why SILREAL?
Direct Dialogue with Stakeholders
SILREAL maintains active channels with Chinese and German regulators, enabling faster policy navigation and market approvals. This ensures clients are not only informed of policy shifts but can actively shape outcomes rather than merely reacting.
Neutral and Trusted Platform
SILREAL is recognized and respected by the German Federal Ministry of Health as a neutral, credible partner in shaping cross-border healthcare policy. This reputation allows clients to engage in sensitive policy discussions with legitimacy and influence.
Proven Policy Advocacy Record & Cross-Border Authority
Through initiatives such as the Sino-European Health Summit, SILREAL has proven its ability to convene ministries, embassies, and industry leaders from both sides while turning policy dialogue into actionable outcomes.
Why SILREAL?
Direct Dialogue with Stakeholders
SILREAL maintains active channels with Chinese and German regulators, enabling faster policy navigation and market approvals. This ensures clients are not only informed of policy shifts but can actively shape outcomes rather than merely reacting.
Neutral and Trusted Platform
SILREAL is recognized and respected by the German Federal Ministry of Health as a neutral, credible partner in shaping cross-border healthcare policy. This reputation allows clients to engage in sensitive policy discussions with legitimacy and influence.
Proven Policy Advocacy Record & Cross-Border Authority
Through initiatives such as the Sino-European Health Summit, SILREAL has proven its ability to convene ministries, embassies, and industry leaders from both sides while turning policy dialogue into actionable outcomes.